Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.126.10 CHF
Change Today +2.10 / 1.69%
Volume 441.2K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
OTC US
As of 11:43 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Paul Clozel M.D.

Founder, Chief Executive Officer, Member of Management Board and Director, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 2 different industries.

See Board Relationships
59SFr.6,866,429
As of Fiscal Year 2014

Background*

Mr. Jean-Paul Clozel, M.D, founded Actelion Ltd. (alternate name Actelion AG ) in 1997 and has been its Chief Executive Officer since April 2000 and serves as its Member of Management Board. Mr. Clozel was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 years, from 1985 to 1997. He serves as a Director of Actelion Ltd. and Actelion Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Founder, Chief Executive Officer, Member of Management Board and Director
Director

Education*

MD
Universite De Montreal, L'

Other Affiliations*

Annual Compensation*

SalarySFr.1,153,335
BonusSFr.1,499,336
Total Annual CompensationSFr.2,652,671

Stock Options*

Restricted Stock AwardsSFr.3,277,135
All Other CompensationSFr.936,623

Total Compensation*

Total Annual Cash CompensationSFr.3,589,294
Total Short Term CompensationSFr.2,652,671
Other Long Term CompensationSFr.4,213,758
Total Calculated CompensationSFr.6,866,429
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.126.10 CHF +2.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
$2.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.